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ONE-STEP SYNTHESIS AND CHARACTERIZATION OF BIODEGRADABLE ‘CLICK-ABLE’ POLYESTER
POLYMER FOR BIOMEDICAL APPLICATIONS

An Abstract of the Thesis by
Wadha Alqahtani

In this study, we have synthesized linear polyester polymers from bio-based small molecules
including sorbitol, glutaric acid and others. A propargylic acid derivative was used to make the
resulting polymer “click”able. Melt polymerization technique was used for this polymerization
reaction using a novel lipase enzyme catalyst, NOVO 435. This reaction was conducted between
90- 95 oC for 72 hours. The polymer samples were collected within 24 h for detailed
characterizations and polymerization reaction monitoring. The resulting polymer was purified
and characterized using various spectroscopic methods such as NMR, GPC, FTIR, DSC and TGA.
Next, these polymers were used for the formulation of polymeric drug delivery system using the
solvent diffusion method and taxol as drug. The results were analyzed by using the cytotoxicity
(MTT) assay using prostate cancer cells , and absorbance and fluorescence microscopy. The drug
delivery experiments and the cytotoxic tests and showed that nanoparticles developed in this
work and successfully effects in drug delivery and can be potentially used for cancer tretment,
that was conducted by using in vitro prostate cancer cell model.
Keywords: nanoparticle, click chemistry, prostat cancer, cytotoxicy
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CHAPTER I

INTRODUCTION

There are only few things which come across the mind of a common man when the word
“Polymer” is discussed. This thought includes the traditional things such as table, chair, bench
etc,. Anyhow, if this term is discussed in depth, then its scope is beyond the traditional
household items and production items. Polymer science is an amazing branch of science and it
has influenced the way of living especially in the past few decade. It has reshaped the lives.
Polymer is helping to solve critical issues related to the traditional materials. This is the core
reason that the Polymer science is further divided into sub-branches such as linear and
branched polymer to make it simple and more useful.
Polymers have revolutionized almost every walk of life and the most effected
department or field in this regard is the field of medicine or the medicine science. One of the
most recent innovation in this context is the invention of “Polymeric nanoparticles”. In the same
manner another contribution is “Dendrite polymers”. These polymers can easily be made with
the help of common chemical available in the market. These polymers are used in the important
applications of the biomedical field such as surgcail system and tissue engineering . This
synthesis require high level of care. So that the intake of such polymers do not harm the body.1
Nanotechnology is the other field of science which is greatly influenced by the polymers.
The deadly and notorious diseases such as cancer are now curable. Polymers have enabled to
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find such methods of treating these diseases which have made the cure predictable and easy.
The traditional techniques such as “Radiation therapy” and “Chemotherapeutics” are replaced
by new technology. These techniques had a lot of side effects and limitations. These are
covered by the use of polymers in the new techniques. The major side effects of these methods
were loss of hair, skin problems, appetite loss, weight loss etc,. These all problems are solved by
the innovation and introduction of nanoparticles in the field of medicine. Nanotechnology is
playing a vital role in this context because these particles can be engineered and designed to
package and transport drugs directly to where they're needed. This targeted approach means
the drugs cause most harm in the particular, and intended, area of the tumour they are
delivered to. This minimises collateral damage to surrounding healthy tissues, and therefore the
side effects.2
The essence of this thesis is the synthesis of two important and frequently used
polymers named as “Hexanediol” and “Decanediol”. Some of the monomers were also used in
this regard termed as “Sorbitol”, “Glutaric Acid” and “Hexyniocacid”. Sorbitol and Gultaric acid
were selected for the process due to their ease of metabolism in the living cell and the hexynoic
acid was used to ensure the surface uniformity during the conversion of alkyne to these nano
particles. This conversion helps the spontaneous up gradation of these particles using the “Click”
Chemistry.
In order to perform this kind of polymeric nanoparticlies synthesis, anticancer medicine
and optical dye were encabculated inside the polymers. These two were “Taxol” and “Dil Optical
Dye”. These both were encapsulated and placed inside the polymers in case of the current
“Drug delivery system”. The incubation process for these polymeric nanoparticles was then
completed with the help of normal prostste cells and LNCaP “postrate Cancer Cells”. The
effectiveness of this nanoparticle as an anti-cancer dilevery system is assessed was tested on
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prostate cancer cells using the MTT cytotoxicity assay. Also in order to show the high affinity
ratio for the folic acid, a PSMA is used. This membrane displays the high affinity because it is
absent in the normal cells. The “Prostate-Specific Membrane Antigen” is expressed by the LNCaP
cells. Maybe you can use the following statement as an ending statement for this

section. "The research presented in this thesis is aimed at the development of a
polymeric nanoparticle that can be used to specifically target cancer cells, thus
providing a better anticancer therapy than the therapeutic methods that are currently
being used.
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CHAPTER II

LITERATURE REVIEW

2.1. History of Polymer
The word polymer has been derived from Greek words “Poly” meaning “many” and “Meres”
meaning “parts”. It is commonly defined as a large molecule formed by a combination of small
repeating or chemical units. These units are called monomers and they combine in thousands to
form a polymer.3 The polymers are considered as the building blocks of life because of their
presence in all classes of the living organisms. They are not only found in nature (such as
chitosan, cellulose, collagen) but can also be synthesized through a process of polymerization.
Renowned synthetic polymers include polyethylene, polypropylene, polystyrene, polyvinyl
chloride, and so on.3-5
In scientific research, the word “polymer” was first introduced by Jons Jacob Berzelius in
his book “Jahres-Bericht”, in the year 1833. One of the earlier attempts to successfully
synthesize a polymer was made by A.V.Lourenco in the year 1860. He made a series of
compounds by using ethylene dihalide and ethylene glycol. In the early 20th century, a
considerable work on polymerization was done by Hermann Staudinger. He studied a wide
range of polymeric compounds and discovered a class of organic compounds known as ketenes.
In the later years, a huge variety of polymers (such as thermoplastic polymers, thermosetting
polymers) were studied, developed and commercialized for widescale applications.6
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Polymers can be classified in a variety of ways based on their origin, polymer structure,
polymerization method, and processing technique. In terms of their structure, polymers can be
classically identified as linear, branched, and cross-linked polymers. A linear polymer is formed
from a bifunctional monomer and is consisted of a long chain of repeating units. Typical
examples include polyethylene, polystyrene, and polyvinyl chloride are the typical examples of
linear polymers.3
The advances in polymer chemistry have led to the development of novel structures
such as the dendritic polymers. These polymers are consist of a central core and a hyper
branched (tree-like) structure containing a large number of terminal groups.7 A structure of an
aromatic polyether dendrimer is shown in the figure 2-1.

Figure 2-1. Structure of an aromatic polyether dendrimer7
2.2. Biodegradable Polymers
2.2.1. Introduction
The history of biodegradable polymers can be traced back to the second half of the 20th
century, when the applications of synthetic biodegradable polymers came into limelight. In the
first half, research on polymer systems such as glycolic acid and hydroxy acids was abandoned
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because of the short usable life of the resulting polymers. This limited lifespan was attributed to
the biodegradability of those polymers. However, in the later decades, this biodegradability was
found to be significantly important for their applications in the biomedical field.8-9 The
first ever biodegradable sutures were developed in the year 1960. Since then, in the early 21st
century, a paradigm shift took place from biostable polymers to biodegradable polymers for
applications in medical and biomedical fields. The biodegradable polymers have been used in a
variety of applications such as drug delivery systems, tissue engineering, therapeutic devices,
orthopedic applications.4,10-11 There classification is given in the following section.
2.2.2. Classification of Biodegradable Polymers
Biodegradable polymers can be classified in a number of ways such as on the basis of
their raw material (bio derived or synthetic monomers) or biodegradation levels (fully or
partially biodegradable).12 In the Figure 2-2, the biodegradable polymers have been classified on
the basis of the monomer origin.
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Polylactic acid
Poly(3hydroxyalkanoate)
Natural Polymers

Polynucleotide
polysaccharides

Biodegradeable
polymers

Polycaprolactone
Polyesters

Synthetic
Polymers

Polyanhydrides
Polyorthoesters

Figure 2-2. Classification of biodegradable polymers on the basis of monomer source12
2.2.3. Biodegradation Routes
The biodegradable polymers can undergo degradation through simple hydrolytic
process or enzymatic degradation. In chemical hydrolysis process, the hydrolytically unstable
chemical bonds in the backbone of the polymer are responsible for degradation. In case of semicrystalline polymers such as polylactides, poly(caprolactone), and polydioxanone, this process
occurs in two stages. The first stage involves the penetration of water to the bulk of polymeric
material, leading to the shortening of long polymer chains through bonds cleavage. These
changes occur only in the amorphous phase of the polymer and the material is held together by
the crystalline phase. Later on, a reduction in molecular weight takes place by the waterassisted fragmentation of the material. In the second stage, enzymes metabolize the fragments
and lead to complete loss of the polymer mass.10,13 Polymers such as polysaccharides and poly
(amino acids) are more susceptible to enzymatic degradation. Some polymers such as
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polyolefins undergo degradation through photochemical process. The bulk of the material is
broken down photochemically and complete degradation is accomplished through
microorganism degradation.14
2.3. Biomedical Application of Polymers
Polymers can be effectively utilized in biomedical applications because of their ability to
conform to living tissues. They can also be tailor made with specific properties such as
mechanical and specific biodegradation capability. Both natural and synthetic polymers can be
used for such applications.13 Their biomedical applications include orthopedic devices, surgical
systems, pharmaceutical applications, tissue engineering applications, ophthalmic applications,
and so on.4,10,13,15-16 The specific polymers used in the above-mentioned applications are often
referred to as polymeric biomaterials or biopolymers.
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2.3.1. Desired Properties of Biopolymers
A biopolymer must possess a number of desirable characteristics for its utilization in the
biomedical field. These are listed as follows.10,11-17
Biocompatibility: it should be non-toxic and noninflammatory upon its implementation into a
human body
Biodegradation: the biodegradation time of the polymer should match the natural healing time
of the body. In addition, its degradation products should undergo complete metabolism and
they should not interfere with the body functions.
Shelf life: the shelf life of material should be reasonable enough for its storage.
Processability and performance: the processability of the biopolymer should be easy and cheap.
In addition, it should serve the intended purpose and possess adequate functionality.
Sterilization: it should be sterializable by using any of the conventional methods such as dry
heating, irradiation, and chemical treatment.
2.3.2. Biopolymer Applications
The biomedical applications of some of the important biopolymers are given as follows,
•

9as biomedical implants. It is a crystalline biopolymer and it undergoes complete
degradation in nearly 3 months. Its major applications include surgical sutures and bone
fixation devices.10,13

•

Polylactides are semi-crystalline in nature and they are widely used for fracture fixation,
augmentation of ligaments, and surgical sutures.13

•

Poly(caprolactone) is a semi-crystalline polymer and is highly processable because of its
solubility in a variety of organic solvents. It possesses excellent biocompatibility and that
is why it is used in a number of applications such as contraceptive devices, nano-sized
drug delivery systems, and as a scaffold in bone tissue engineering.11,13
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•

Polydioxanone is semi-crystalline in nature and it possesses a degradation time of nearly
7 months. The first commercial monofilament suture was made from polydioxanone in
the year 1980. It finds application in orthopedic devices such as osteochondral
fragments and bone fixation screws.4,13

a

b

c

d

Figure 2-3. Some biopolymer applications, (a)-Commercial polyester-based meniscal repair
devices,17 (b)-Poly(caprolactone) based spacer and reinforcement screw ﬁxation 17, (c)- Carbon
fibre Poly-ether-ether-ketone based osteosynthetic plates,18 (d)- Poly-ether-ether-ketone
interference screw 19
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2.4 Polymeric nanoparticles and their Role in Cancer Treatment
2.4.1. Introduction to Nanoparticles
In the last decade, nanoparticles have gained interest of the researchers in the medical
field because of their targeted drug delivery capabilities.20-23 These particles are specifically
engineered to have dimensions in the nanometre range (10-9). They can be distinctively
categorized into layers, tubes, and spheres on the basis of their dimensions in the nanometre
range. For example, the particles having at least two dimensions in the nanometre range and
possessing elongated structure are referred to as nanotubes. 22,24 These nanoparticles can be
read from a variety of materials such as noble metals (gold, silver),21 nonmetals (carbon, silica),24
and polymers.25 There are variety of material designs of polymer nanoparticles that can be
effectively used for drug delivery in any medical treatment such as cancer therapy. These
include nanospheres, nanocapsules,26 and liposomes.27 There self-explanatory structures are
given in the figure 2-4.

(a)

(b)

(c)
11

Figure 2-4. Structures of polymer nanoparticles, (a)-Nanosphere,25 (b)-Nanocapsule,26 (c)Liposome design 27
2.4.2. Preparation of Nanoparticles
There are a number of methods for the preparation of polymer nanoparticles such as
solvent evaporation, solvent diffusion, and nanoprecipitation. The solvent diffusion method (as
shown in the
Figure 2-) is also referred to as emulsification solvent diffusion method and it is a
modified form of the solvent evaporation method. It involves the dissolution of encapsulating
polymer in a solvent (partially soluble in water) and then saturating the mixture with water. This
mixture is then emulsified by using an emulsion stabilizer. As a result, the solvent diffuses to the
external face and formation of nanoparticles takes place.26

Figure 2-5.Illustration of solvent diffusion method28
2.4.3. Characterization of Nanoparticles
There are a number of techniques used for the characterization of size, morphology, and
surface characteristics of nanoparticles. The commonly used techniques are scanning electron
microscopy, transmission electron microscopy, and atomic force microscopy.29 The different
properties of nanoparticles and their respective characterization tools or methods are given in
the given table 2-1.
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Table 2-1. Characterization techniques and methods for nanoparticles 29
Property

Characterization Method/Techniques
Laser diffractometry

Particle size & distribution

Photon correlation spectroscopy
Scanning electron microscopy
Transmission electron microscopy

Surface charge determination

Drug stability

Release proﬁle

Surface hydrophobicity

Laser Doppler Anemometry
Zeta potentiometer
Bioassay of drug extracted from Nanoparticles
Chemical analysis of drug
In vitro release characteristics (physiologic & sink
conditions)
Water contact angle measurement
X-ray photoelectron spectroscopy

2.4.4. Drug release
An important area in drug delivery or discovery is the targeting of a drug to infected
cells or tissues without interfering with the healthy cells. Advancement in the drug targeting
systems have made it possible to estimate about the ultimate fate of a drug in the human body.
The drug can be targeted to the desirable site by using any of the two mechanisms such as
active or passive targeting. Active targeting involves the surface functionalization of carrier
nanoparticles with ligands. The receptors on the surface of targeted cells are able to selectively
recognize these drug carriers. In passive targeting, in cancer treatment example, the
chemotherapeutic agents are accumulated in infected cells or tumors.29
In the area of site-specific drug delivery, polymer nanoparticles offer a number of
advantages. They can effectively deliver drugs to various organs (large or small) of the body by
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overcoming the physiological barriers. Their physical attributes (such as particle size, surface
features) can be engineered for a specific treatment system. They offer improvement in
bioavailability and can reduce the side effects or toxicity of a drug to other organs. A number of
drugs such as Cisplatin, Doxorubicin, and Cyclosporine-A can be delivered through polymeric
nanoparticles for treatment of multiple cancers.29,30
2.4.5. Targeted drug delivery
At present, there is a limited variety of drug delivery nanoparticles which have been
approved by the United States Food and Drug Administration (US-FDA). The first ever
nanoparticles-based drugs for cancer therapy were the Liposomal drugs. They were used in two
formulations such as Doxil® (pegylated liposomal doxorubicin) and DaunoXome® (pegylated
liposomal daunorubicin).22 For treatment of breast cancer, albumin-based nanoparticle drug
delivery system (Abraxane®) was also established and approved by the US-FDA for commercial
application.31Myocet® is a commercial name of nonpegylated liposomal doxorubicin.
Doxorubicin is an important medication used for treatment of a variety of cancers such as
leukemia, breast cancer, lung cancer, Hodgkin's disease, and so on. This drug has been studied
and approved by the European Medicines Agency for treatment of metastatic breast cancer in
women above 18 years of age.32
2.5 Evalution of cancer treatment
2.5.1. Introduction to cytotoxicity assays
The cell cytotoxicity is generally referred to as the ability of mediator cells or certain
chemicals to destroy healthy living cells. By determining the cytotoxic nature of compounds
(especially pharmaceuticals), their impact on human health can be identified and end-user
safety could be ensured. In order to choose a cytotoxicity assay, an in-depth understanding of
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the measured endpoint, correlation of measurement with cell viability, and knowledge of assay
chemistry is very essential.33
2.5.2. Various Cytotoxicity Assays
The commonly used cytotoxicity assays 34-35 are as follows.
•

MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2Htetrazolium)

•

MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide

•

SRB (Sulforhodamine B)

•

XTT (2,3-Bis-(2-Methoxy-4-Nitro-5-Sulfophenyl)-2H-Tetrazolium-5-Carboxanilide)

•

ATP (adenosine triphosphate) formation

•

[3H]-thymidine incorporation

2.5.3. Cytotoxicity Applications
The cytotoxic compounds can be effectively used for inducing programmed (apoptosis)
or accidental death (necrosis) to the living cells. For example, targeted delivery of a therapeutic
protein (such as Cytochrome-c encapsulated in polymeric nanoparticles) to cancer cells can lead
to a selective apoptosis in the cells. On the other hand, the healthy cells are not affected by the
therapeutic protein. As a result, such cancer therapies hold considerable importance in modern
medical research.36-37
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CHAPTER III

RESULTS AND DISCUSSION

3.1. Polymers Synthesis and Characterization
Highly biocompatible and hydrophilic compounds were selected for polymer synthesis. To
enable the “click” chemistry after the conversion of polymer to nanoparticle suspension, the
reagent (hexynoic acid) was chosen so that the surface chemistry of the polymer can be tuned.39
The polymer was synthesized by the melt polymerization process with Novozyme-435 used as
enzyme catalyst. Sorbitol, hexanediol, glutaric acid, and hexynoic acid were used as reagents for
polymer synthesis in the molar ratio of 1:0.9:2:0.4, respectively. Polyols were provided in
equimolar ratio, whereas glutaric acid was provided in excess to ensure the esterification
between polyols and glutaric acid. On the other hand, the chances of reaction between hydroxyl
groups and hexynoic acid were reduced by providing hexynoic acid in molar deficit. In another
reaction, decanediol was used as one of the reagents under similar conditions. Figure 3-1 shows
the proposed reaction scheme for the synthesis of polyester polymers 1and 2.
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Figure 3-1. Synthesis of new polyester polymers from biodegradable monomers

3.1.1. Nuclear Magnetic Resonance Spectroscopy (1H NMR) of Polyester-1:Figure
3-2 shows the proton NMR spectra of the starting materials used in this study. The peak at 0
ppm was assigned as TMS reference peak. In each spectrum, the peak at 2.5 ppm was assigned
to DMSO-d6 solvent. The aliphatic secondary protons in sorbitol were found in the peak cluster
at 3.3 -3.8 ppm while the aliphatic primary protons were found in the peak cluster at 4.1-4.9
ppm. The peaks at 1.7 ppm in glutaric acid and hexynoic acid spectra was indicative of
methylene protons. The alkyne peak of hexynoic acid was observed at 2.9 ppm. The proton peak
in hexanediol was observed at 3.5 ppm. The characteristic peak for the carboxyl hydrogen which
is usually found at 10-12 ppm was not observed in the spectra of glutaric acid and hexynoic acid
due to the hygroscopic nature of the solvents used in the sample preparation for 1H NMR
spectra. The shallow peak at 3.40 ppm is a clean indication of hydroxyl group in the sample of
glutaric acid.40
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Figure 3-2. 1H NMR spectra of starting compounds of polyester polymers-1,2
The spectrum Figure 3-3 of the synthesized polyester-1 after 48 h of the reaction is compared
with the spectra of monomers in Figure 3-2. The characteristics peaks of the monomers were
discussed in the previous section. All the important peaks were observed in the 1H NMR spectra
of polyester polymer-1. For example, aliphatic protons of sorbitol structure were found at peak
clusters of 4.1 and 4.9 ppm. The proton peak in hexanediol was observed 3.8 ppm in the spectra
of polyester polymer-1. The alkyne peak of hexynoic acid was observed at 2.23 ppm in the
polymer-1 spectra. These analyses indicated the successful polymerization of reagents under
current experimental conditions.
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Figure 3-3. 1H NMR spectrum for monomers and 48 h of polyester polymer-1
The 1H NMR spectra of the synthesized polyester polymer-1 at different time intervals is
shown in Figure 3-4. The spectra were compared after 24, 48, and 72 hours. No change in the 1H
NMR spectra was observed after 48 hours which shows the completion of polymerization
reaction after 48 hours.
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Figure 3-4. 1H NMR spectrum of different times for polyester polymer-1
3.1.2. 13C NMR Polyester-1
13

C NMR spectra of monomers and polyester polymer-1 are shown inFigure 3-5, Figure

3-6, and Figure 3-7. In each spectrum, a strong solvent peak for DMSO-d6 was observed at 40
ppm. The peak at 173 ppm in hexynoic acid and glutaric acid represented carbonyl carbon. At
68.7 ppm, the peak represented the terminal alkyne carbon of hexynoic acid. The peak at 60
ppm was assigned to carbons of hexanediol in 13C NMR spectra hexanediol. Aliphatic carbons of
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sorbitol were observed at 61-65 ppm. At 33 ppm, the carbon next to carbonyl groups in
hexynoic acid and glutaric acid was manifested. The carbon next to alkyne bond in hexynoic acid
was observed at 21 ppm.
All these peaks with small shifts were observed in the 13C NMR spectra of polyester
polymer-1 as shown in Figure 3-6 which shows polymerization of monomers. The spectra of
polyester polymer-1 at different intervals is shown in Figure 3-7. At 48 h, distinct spectrum was
observed which shows the completion of polymerization reaction.

21

Figure 3-5. 13C NMR Spectra of Starting Compounds
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Figure 3-6. 13C NMR Spectrum of monomers and 48 h of polyester polymer-1
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Figure 3-7. 13C NMR Spectrum of different times of polyester polymer -1
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3.1.3. 1H NMR of Polyester-2
1

H NMR spectra of the polyester polymer-2 along with its monomers is displayed in

Figure 3-8 and Figure 3-9. The spectra of monomers have been discussed in detail in the
previous section. For polyester polymer-2, the spectrum was found to be identical to polyester
polymer-1 and its identification is similar to the aforementioned as well.

Figure 3-8. 1H NMR spectrum for monomers and 48 h of polyester polymer-2
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Figure 3-9. 1H NMR spectrum of different times for polyester polymer-2
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3.1.4. 13C NMR of Polyester 2
Similarly, the 13C NMR spectra of polyester polymer-2 are displayed in Figure 3.10 and
Figure 3.11. The 13C NMR spectrum of polyester polymer-2 matched the spectrum of polyester
polymer-1. Hence, it confirmed the successful polymerization of the monomers.

Figure 3-10. 13C NMR Spectrum of monomers and 48 h of polyester polymer-2
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Figure 3-11. 13C NMR Spectrum of different times for polyester polymer-2
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3.1.5. Fourier transform infrared spectroscopy (FTIR):
Figure 3-12 and Figure 3-13 show the FTIR spectra of polyester polymers 1-2 after 48 h
of reaction compared with monomer materials. Most importantly, the ester carbonyl (C=0) bond
was observed at a 1712 cm-1 in the form of a distinctive strong peak for both polymers.41 This
peak is a clear indication of successful polymerization of the monomers. Furthermore, a strong
peak at around 1146 cm-1 shows C-O stretching from ester and aliphatic ether linkages (from
diols) is also a confirmation of successful polymerization of the monomers.

Figure 3-12. FTIR spectra of monomers and 48 h of polyester polymer-1
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The aliphatic alkyl bond stretching (C-H) was observed at 2900 cm-1. The hydroxyl (O-H)
groups of the sorbitol monomer were observed at stretching band of 3350-3580 cm-1 in the
form of broad and shallow peak. Alkyne stretching from (C≡C) of hexanoic acid was observed at
2180-2220 cm-1 in the form of weak peaks due to low concentration of hexynoic acid in the
reaction mixture. The presence of these characteristics peaks is an indication of successful
polymerization of polyester polymers 1-2 after 48 h.

Figure 3-13. FTIR spectra of monomers and 48 h of polyester polymer-2
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3.1.6. Gel permeation chromatography (GPC ):
The results obtained from GPC analysis of each monomer sample are seen in Figure
3.14. The elution of each monomer was observed at the characteristic time of each monomer in
the form of a single distinct peak. This shows the purity of the monomers. Figure 3-15 shows the
molecular weight of polyester polymer-1 after 48 hrs. of reaction compared with molecular
weight of monomers in Figure 3-14 founding that high molecular weight was observed at 31
minutes. GPC spectra of polyester polymer-1 after different time intervals is displayed in Figure
3-16. Elution of high molecular weight product was observed in the spectra at around 30-35
minutes for various reaction times. With the increase of reaction time, elution of polymer traces
was observed at 30 minutes for 72 h showing that the product was of higher molecular weight

MW

range compared to 24h and 48 h.

Minutes
Figure 3-14. GPC of all monomers of polyester polymer-1
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MW

Minutes
Figure 3-15. GPC of monomers and 48 h of polyester polymer-1

Minutes
Figure 3-16. GPC of different times of polyester polymer-1
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This was further analyzed by the estimation of number average molecular weight”Mn,”
weight average molecular weight “Mw”, and Polydispersity Index “PDI” of each polymer sample
as shown in Table 3-1. Thus, the value for high molecular weight polyester was observed for the
72 h product. However, the PDI was lower for the 24 polymer sample. Therefore, 48 h was
found to be the optimal time for the synthesis of polyester polymer-1.
Table 3-1.. Progress of the polymerization reaction as mentioned by GPC of polyester polymer-1

Based on this observation, polyester-2 was synthesized at 48 h conditions and GPC
spectrum is shown in Figure 3-17. The spectrum was also compared with monomers in Figure 314. High molecular weight polyester was observed at 27 minutes in GPC spectra of polyester
polymer-2 synthesized by decanediol. This shows that when subjected to equal reaction
conditions, polyester polymer-2 was higher in molecular weight compared to polyester polymer1 synthesized with hexandiol. This difference was also observed in MALDI analysis which
confirms higher molecular weight of polyester polymer-2.
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Minutes
Figure 3-17. GPC of monomers and 48 h of polyester polymer-2

Table 3-2..Progress of the polymerization reaction as mentioned by GPC of polyester polymer- 2

3.1.7. Matrix Assisted Laser Desorption Ionization (MALDI-TOF):
Figure 3-18 and Figure 3-19 show the MALDI-TOF scanning of the synthesized polyester
samples. For polyester-1 sample, large fragments with Mn of 4654 were observed in Figure 318. However, the MALDI-TOF results of polyester-1 sample shows that the polymer was of polydispersed nature. In case of polyester-2 sample, fragments with Mn values of 27675 were
observed as can be seen in Figure 3-19. Polyester-2 sample was also found to be poly-dispersed.
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Mw based on MALDI-TOF results was calculated by using polydispersity index (PDI) of
1.2 and 1.7 obtained from GPC analysis. PDI was found to be lower than the typical value of
synthetic polyesters which might be due to uniform chain length of the synthesized
polyesters.42,43 Using the equation (PDI=Mw/Mn), Mw was found to be 23,320 and 58,772 for
polyester-1 and polyester-2, respectively. Polymer-2 exhibited high molecular weight compared
to polymer-1 which is in-line with GPC analysis and can be attributed to higher chain length of
decanediol.
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Mn
Figure 3-18. MALDI-TOF of 48h polyester polymer-1

Mn= 34583

Mn= 19554

Mn
Figure 3-19. MALDI-TOF of 48h polymer polyester-2
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3.1.8. Thermogravimetric analysis (TGA):
As shown in Figure 3-20 and Figure 3-21 display the TGA analysis of the two polymer
samples. Both polymers displayed a continuous weight loss starting from 25oC until 370oC
before the onset of thermal degradation of polymer backbone. This is an indicative of the
presence of moisture in the polymer samples showing hydrophilicity of the material.
Nevertheless, the polymers were found to be thermally stable at biological temperature (37 oC)
which shows the suitability of the synthesized polymers in biomedical applications.

Figure 3-20. TGA of 48h polyester polymer-1
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Figure 3-21. TGA of 48h polyester polymer-2
3.1.9. Differential scanning calorimetry (DSC):
Differential Scanning calorimetry analysis of the synthesized polymers was performed and
transition temperatures were found out. Differential scanning calorimetry is a technique that is
used to find out the glass transition temperature (Tg), crystallization temperature (Tc) and melting
temperature after cooling or crystallization (Tm). A typical curve of differential scanning
calorimetry shows the heat-cool cycle. As shown in Figure 3-22 both the polyester polymers were
heated and cooled again between the range of -80 0C and 120 0C. A glass transition temperature
(Tg) was observed for first and second polymers at -35.16 0C and -37.35 0C respectively. The lower
Tg show the samples are biodegradable, also low Tgs conformed that both polyester polymers are
amorphous . The polymers were then cooled, leading to crystallization in the structure. Following
crystallization, polymers were again heated. The melting temperature of first and second
polymers was found to be 19.45 0C and 25.89 0C respectively. The type of polymer-1 had a lower
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Tg as compared to type of polymer-2, this means their mechanical strength was less as compared
to second type, and they also may degrade earlier as compared to second type of polymers.

Figure 3-22. DSC of 48 polyester polymers1-2
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3.2. polymeric nanoparticle synthesis and characterization:
Following characterization, the polymers were converted into polymeric nanoparticles (PNPs)
for drug and dye encapsulation utilizing a “solvent diffusion” and “encapsulation” methods.
Solvent diffusion method is an aqueous method in which the solid lipid nanoparticles are
effectively prepared. While the encapsulation method is the process in which the nanoparticles
are covered with a coating.This method is used to incorporate tiny particles in the new particles
to form the nanoparticles.44 Figure 3-23 expains the process of synthesis of nanoparticles
followed by characterizations of these nanoparticles.

Figure 3-23. Conversion of polymer to nanoparticles and surface ligand modification
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3.2.1. Dynamic light scattering (DLS):
Dynamic light scattering is a characterization techniques used to find out the size of
nanoparticles, the size distribution range of particles. Figures 3-24 and 3-25 show Dynamic Light
scattering analysis of polymeric nanoparticles synthesized using hexanediol (first) and decanediol
(second) gave the size distribution for both types of polymeric nanoparticles. Size distribution
curve shows that first type of polymeric nanoparticles had an average size of 78.82 nm. On the
other hand, second type of polymeric nanoparticles had an average size of 189.5 nm. The
difference in the size distribution of the two types of polymeric nanoparticles can be attributed
to the different types of diols used. In case of first type, hexanediol was used, which has a shorter
carbon chain i.e. the diol carbon length is 6, whereas for second type, in which decanediol was
used, the diol carbon length is longer, containing 10 carbons, this can result in larger particle size.
First type of synthesized polymeric nanoparticles had smaller size range as compared to the
second type of polymeric nanoparticles. However these sizes make nanoparticles capable of
crossing in-vitro cells.

78.82 nm

Figure 3-24. Dynamic light scattering of PNP-1

41

189.5 nm

Figure 3-25. Dynamic light scattering of PNP-2
3.2.2. Zeta Potential Determination
In these studies, Zeta Potential measures the charge repulsion or attraction between
functional groups on the surface of the nanoparticles. For the Zeta potential measurements to be
valid, the nanoparticles must be placed in a conducting medium such as water. This difference is
calculated by Zeta potential. Figure 3-26 shows the zeta potential for the first type of polymeric
nanoparticles, synthesized using hexanediol. Zeta potential is the electrostatic charge on the
synthesized nanoparticles. For hexanediol polymeric nanoparticles, the average zeta potential
was found to be -18.4mV. These particles are highly negatively charged as shown by the results.
While Figure 3-27 shows the zeta potential of second type of polymeric nanoparticles synthesized
using decanediol. Zeta potential of these particles ranged from -1.24mV to -3.27mV. These
particles are also negatively charged, but not as strongly negatively charged as first type of
polymeric nanoparticles. These particles are less negatively charged as compared to first type of
synthesized nanoparticles. This can be attributed to the different lengths of the diols used in both
polymer types. The overall charge on nanoparticles effects cellular uptake ability and hence the
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drug delivery function.45 In this case, the synthesized polymeric nanoparticles will be
further functionalized to make them clickable with folate groups, so the surface charge will be
covered.

-18.4mV

Figure 3-26. Average surface zeta potential of PNP-1

-3.27mV

Figure 3-27.Average surface zeta potential of PNP-2
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3.2.3. Absorbance and Fluorescence:
Following encapsulation of DiI and surface decoration with folic acid, the nanoparticles
were analyzed by absorbance and fluorescence spectroscopy. This was performed to determine
the presence of DiI dye and folic acid after the completion of synthesis and dialysis, as well as to
determine if they maintained their activities after encapsulation. The results of these analyses
are shown in Figure 3-28 and 3-29.
The absorbance spectra for the PNP 1-2 presented in Figure 3-28 showed a peak at 370
nm which corresponds to folic acid and two peaks between 510-570 nm which correspond to Dil
dye. This indicated that the cargo molecules were present within the nanoparticles and the folic
acid ligands conjugated to the surface maintained their absorbance through the synthesis and
purification. The somewhat broadened absorbance for DiI was likely due to the polymer matrix
and the media (deionized water) in which the nanoparticles were suspended, which can cause
absorbance to deviate slightly from the expected values.

Figure 3-28. Absorbance of PNPs 1-2 with encapsulated DiI Dye and Folic Acid
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Figure 3-29 represents the fluorescence emission spectra of PNP 1 and 2 with
encapsulated Dil Dye. The spectra show characteristic emission spectra of dye
encapsulating polymeric nanoparticles. Fluorescence intensity maxima of the polymeric
nanoparticles around 570 nm shows and confirms the presence of Dil dye in both PNPs.
This shows that Dil dye was successfully encapsulated in the polymeric nanoparticles.
High fluorescence intensity is observed in both the cases, showing strong fluorescence
emissions. Both the Dil encapsulating polymeric nanoparticles can be used for in vivo
imaging. Cells can be effectively tracked using these nanoparticles.

Figure 3-29. Fluoresance emission of PNPs 1-2 with encapsulated DiI Dye
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3.2.4. MTT assay
MTT assay displays the cytotoxic effect of the nanoparticles as they are incubated with
the cells. Using a 96 well-plate, LNCaP and normal prostate cells were cultured in 96-well plate.
50 uL of each (1) propargyl-PNP and (2) PNP-folic and (3)PNP-taxol for both nanoparticles samples
were incubated with the cells for 24h at 370C and 5% CO2 atmosphere. After the incubation, the
cells were treated with the MTT/ Phosphate-buffered saline (PBS) solution and incubated for an
additional 4-6 hours. Figure 3-30 gives the cytotoxicity analysis of the synthesized polymers using
MTT assay. The control group displayed no cytotoxicity and was used as reference to measure
cytotoxicity of the synthesized polymeric nanoparticles. It was observed that the second type of
polymeric nanoparticles showed higher cytotoxicity as compared to first type of polymeric
nanoparticles. For the propargylated polymeric nanoparticles, cell viability was observed as
compared to the control for first and second type of polymeric nanoparticles synthesized using
hexanediol and decanediol showed slight cytotoxicity. For folate-labeled PNPs significant toxicity
was observed compared to all other types of PNPs used on the assay. These results indicate the
ability of folate PNPs to be uptaken by cells greater as compared to propargyl loaded PNPs. For
Taxol labeled PNPs, high cytotoxicity was observed for synthesized polymeric nanoparticles.
Second types of PNPs labelled with Taxol were the most cytotoxic. The results show that
polymeric nanoparticles labelled with folate, taxol, and synthesized using hexanediol killed cancer
cells less efficiently than those synthesized with decanediol, though only by approximately 20%.
Taxol encapsulated PNPs are the best for use in anticancer drug delivery as shown by the results.
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Figure 3-30. Cytotoxicity Effects of PNPs 1-2 on LNCaP Prostate Cancer Cells
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CHAPTER IV

EXPERIMENTAL METHODS

4.1. Materials:
Five compounds were used as biodegradable monomers to prepare both polyester polymers.
Sorbitol, glutaric acid, hexynoic acid, hexanediol, and decanediol were purchased from Sigma
Aldrich and used as received. Deuterated dimethyl sulfoxide (DMSO-d6) was purchased from
Sigma-Aldrich and used in 1H NMR and 13C NMR spectroscopy. Variety of solvents utilized to
determine solubility of the polymers. Methanol (MeOH), tetrahydrofuran (THF), dimethyl
sulfoxide (DMSO), and other chemicals were purchased from Sigma-Aldrich and used without
furtherpurification. The fluorescent probe dye 1,1′-dioctadecyl-3,3,3′,3′tetramethylindocarbocyanine perchlorate (DiI) used as a surrogate for hydrophobic drugs and
chemotherapy drug (taxol) to target cancer cells and causes these cells to die were obtained
from thermofisher. 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), and 4'
6-diamidino-2-phenylindole (DAPI) were purchased from Biotium. LNCaP and PC3 prostate
cancer cells were obtained from the American Type Culture Collection (ATCC) organization and
cultured per their supplied protocol.
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4.2. Synthesis of polyester polymer:
The experimental setup for the raw materials was done in a round bottle flask of 50ml capacity.
One of three components were added and melted at temperature of 140°C which included the
Sorbitol, glutaric, hexynoic and either hexanediol or decanediol. All of them were considered in
quantities of 3.44g, 5g, 1.58, 3, or 3.29g in mmol. Another component, novozyme-435 was then
added in quantity of 400mg after cooling initial melt till 95°C. this element was added to act as
catalyst for esterification reaction. Inert atmosphere was created for the flask with the help of
Schlenk line containing the nitrogen gas in pure form 12 hours and then entire vacuum process
was begun for the next 72 hours at very high value of 4x10-4 mm/Hg. While the compounds were
added in quantities of 1.5 to 2g, there were three samples collected for 24, 48 and 72 hours in
vacuum. Each of the treated samples was then purified with the help of methanol dissolving and
filtering with P8-grade filter paper. This was done for separating the polymer solution from
catalyst. The methanol was then removed from the 50 ml flask by placing it in the evaporator at
60°C. additional vacuum treatment was given to ensure complete elimination of methanol
component. The structure of both polymer samples were different, first was similar to wax and
second was similar to molasses in terms of texture and viscosity. While they both showed
insolubility in water, contrary was observed when treated with dimethyl sulfoxide (DMSO),
methanol (MeoH), tetrahydrofuran (THF), and toluene.
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4.3. Synthesis of Polymeric Nano-particle:
For this synthesis the 30 mg of the polymer was put in the “Eppendorf Tube” and it was then
dissolved in the 250 micro liter DMSO solution. Then 2 micro liter of Taxol and 2 micro liter of Dil
Optical Dye were added to this suspension. This solution or the mixture was then vortexes at
1500 revolutions per minute for 3 minutes. A 15 milli liter centrifuge tube was then used to
carry the resultant mixture. The mixture was dropped slowly and the constant vortexing was
done. The tube was carrying 4 milli liters of H20 in itself.
The centrifuge tube was locked after the complete addition of the suspension and the
speed of vortexing was increased from 1500 rpm to 2500 rpm. And the dye and drugs having
nanoparticles encapsulated in them were turned into faint pink color. After the completion of
the process the suspension was then poured into a “Porous Dialysis Sleeve”. The MWCO=3.6
kDa was used in this context. This was used for the dialytic purification process. And in the
presence of the de-ionized water for about one hour.
4.4. Folic Acid Conjugation:
The selected treatment of the LNCap prostate cancer cells could only be done after changing the
functional group found on surface. The high chemistry with the Azide functional groups in folic
acid could be explained on the basis of triple carbon bonds found in extracted functional groups.
For the selective performance of the LNCaP cells, folic ligands were combined with them which
enhanced the expression of folate receptors at surface level of cells. The next section gives brief
intro to synthesis and preparation of Fol-N3.
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Figure4-1: Synthesis of Azide-Functionalized Folic Acid
The first step in modification was to prepare aminopropl azide which was done by
combination of 3-bromopropyl amine (7 g, 0.051 mol) and sodium azide (14.23 g, 0.219 mol) in a
round bottom flask of total volume 100 mL. the flask was initially filled with deionized water and
after addition of other compounds, was heated at 80°C for next 20 hours. The next steps included
the removal of solvent by rotary evaporator under vacuum, followed by reaction with potassium
hydroxide and extraction perform with petroleum ether.
The next step in the synthesis of Folic acid was its dissolving in DMSO (2 mL). in another
apparatus a combination was performed for 1-Ethyl-3-(3-dimethylaminopropyl) carbodiimide
(EDC) (0.02 g, 0.129 mmol) and N-Hydroxysuccinimide (NHS) (0.013 g, 0.113 mmol) with in 2-(Nmorpholino) ethanesulfonic acid (MES) Buffer (0.5 mL, pH 5.0). this combination was followed by
incubation for 3 minutes, after which dissolving occurred in PBS (0.025 mL). this reaction was
completed in duration of 3 hours with drop wise addition of PBS. The last step was centrifugal
process at 5000 RPM where the azide functionalized folic acid was collected.
The azide functionalized folic acid was then dissolved and combined with DMF (0.02 mol)
and nanoparticle solution of bicarbonate buffer, respectively. This was done to ensure bonding of
acid with nanoparticles. The reaction of acid was done with copper iodide (0.001 mmol) in DMF
(5 µL) followed by incubation process occurring at table mixture of duration of 12 hours. The
process of dialysis was performed for acid with deionized water and its was finally stored at 4°C.
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4.5. Instrumentation:
1

H NMR: either (1 mL) of chloroform or DMSO-d6 was used for dissolving monomer or polymer

samples in quantities of 15-20 mg or 50 mg, respectively. The process of scanning was performed
in DPX-300 M Hz spectrometer with help of TOPSIN 1.3 system to obtain 25 scans. Drying process
then occurred in vacuum for making it suitable to dissolve in deuterated solvent.
13

C NMR: this process contained dissolving of monomer and polymers in DMSO-d6 (1 mL). in this

method the same TOPSIN 1.3 system was used while processing of samples was done with Bruker
DPX at 300 M Hz to get 1000 scans. Similar vacuum drying process was used to make it suitable
for dissolving in deuterated solvent.
FT-IR: the Perkin Elmer Spectrum, 2 FT-IR spectrometers were used 15 mg for treating the
monomers and polymers. They were each scanned for getting their spectrums. Similar vacuum
drying process was used.
Gel Permeation Chromatography (GPC): Water 2410 DRI gel permeation chromatograph was
used for this technique. The apparatus and materials consisted of four phenogel columns that was
containing the polystyrene-divinylbenzene (PSDVB) beads in a cross linked manner. After drying
polymer with vacuum drying process, they were dissolved in THF (1 mL) before tranfering them
to GPC vial. The flow rate of THF used for this process was 1Ml/min to occur at 25 degree Celsius
for 50 minutes.
Thermogravimetric Analysis (TGA): TA instruments Q50 thermogravimetric analyzer was used to
study the thermal stability of polymer. Samples were taken in 5 mg quantities and then
equilibrated followed by a heat treatment through nitrogen conducted by heat changing rate of
10°C per minute. The entire procedure required 60 minutes for completion where the
temperature ranged from 25°C to 600°C.
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Differential Scanning Calorimetry (DSC): Q100 differential scanning calorimeter was used with
required guage paramters for this process. Weighted samples of polymers were used in 7-8 mg.
the process completed in 3 cycles where temperature varied from -70°C to 120°C with rate of
change of 10°C/minute. The samples was kept at constant temperature in isothermal period
before initiation of next cycle.
Matrix-Assisted Laser Desorption/Ionization-Time of Flight (MALDI-TOF):
Bruker microflex™ LRF MALDI-TOF, system was used for this process. Matrix samples were selfprepared. The initial step was to prepare 100 µL TA30 solvent, with 30:70 ratio of acetonitrile to
0.1% trifluoroacetic acid. The matrix was obtained by dissolving the prepared TA30 solvent with
2,5-dihydroxybenzoic acid (2 mg). Next step included moisturization by vacuum dryer, desiccated
and solution with methanol. Eppendorf tube was then used for combining polymer solution and
TA30 matrix. Steel MALDI target plates were used for spotting the solution which were left for
drying for about 6 hours and then spectrometric scans were observed under mass spectrometer.
Dynamic Light Scattering and Zeta Potential: polymer solution was mixed with the deionized
water in quantities of 10 µl. and 1 milli liter respectively. standard and electrode containing
cuvettes were used for the DLS and zeta potential analysis. Malvern ZS90 zetasizer was used for
the cuvette examination in which program was programmed for obtaining data at rate of 50
readings in 3 cycles.
Uv/Vis and Fluorescence Analysis: Tecan infinite M200 Pro microplate readers were used as
apparatus for UV and fluorescence examination. 96-well plate contained 70 µl of the samples in
volumetric quantities and examined through spectrophotometer. The scans were done for 300 to
800 nm wavelength range for absorption and range of 600 to 900 nm was set for the fluorescence
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scanning. Data was obtained after differential increase of 5 nm with 10 flashes in single data
acquisition. Comparison of the two plots obtained was done on Microsoft excel.
4.6. Cell Studies
Cell Culturing: : There was a special formulation created for growth of LNCaP and PC3 cancer cells.
The formulation contained three components in different ratios by volume 85% RPMI-1640
media, 10% fetal bovine serum, and 5% Penicillin/Streptomycin antibiotic. The compounds were
kept intact at 4°C after filtering by vacuum. Cryo cells were kept in this medium, then placed onto
7-mL flask and incubated at 37°C. for achieving longevity and to avoid overcrowding of cells, they
were divided into two different flasks containing same medium. Those cells were used for
examination that had been in media for more than 24 hours or had achieved confluency of 80%.
MIT Assay: The medium for this examination contained fresh cells placed on 96-well plate which
already contained 50 uL amount of polymer nanoparticle formulations for 24 h. The cells were
then washed with addition of 50 µL of 1X PBS after incubation process. Further incubation for 4
to 6 hours was then done for cells by addition of 25 uL of MIT solution. Followed by incubation
was addition of 30 uL isopropanol after removing MIT solution from wells. Now, TECAN infinite
M200 PRO multi-detection microplate reader was used for analysis of cells in order the analyze
the effectiveness of nanoparticle processing.
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CHAPTER V

CONCLUSION

The biocompatible monomers were used in the thesis for the synthesis of a “Hydrophobic
Polyester Polymer”. Different features of the polymers were considered. These features which
include thermo stability, molecular weight and the alkyne surface uniformity were modified to
form a drug delivery system. The experiment was successful and the polymers were converted
to the “Polymeric Nanoparticle Suspensions” effectively. And the resultant suspensions included
the alkyne surface functionality and biologically effective Nano-scale diameters. The surface
functionality was successfully introduced using using “Click” chemistry. The anti-cancer drug
and the optical dye encapsulation within the polymer was also successfully accomplishe. The
specificity and the efficacy of the nanoparticles were shown by Cytotoxicity assay using prostate
cancer cells. After 24-hour incubation of Taxol-nanoparticles with prostate cancer cells,
polymeric nanoparticles PNP-1 and PNP-2 resulted in 60% and 80% cell death, respectively.
Future work will involve the use of Fluorescence microscopy as a tracking tool to trace
the optical dye incapculated in the nanoparticles to determine the efficiency of their
accumulation in cancer cells, a neccassary step needed in order to ultimately be able to market
these products as an effective drug delivary system. Moreover, more work is needed to
quantatively determine the optimal concentration of the optical dye needed to obtain the
clearest image and the optimal amount of taxol that will lead to maximum cell death. Other
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nanoparticles with more improved properties that will make them more effective as drug
delivary systems will be explored. Ultimately, experiments using animal models will be used to
test the efficacy of these nanoparticles as drug delivery systems. .
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